Huahui healthcare
Web13 feb. 2024 · 10. On February 6, Huahui Health registered a Phase II clinical trial (NCT05713318) on the website clinicaltrials.gov to evaluate the efficacy and safety of its self-developed nasal spray HH-120 in the treatment of mild SARS-CoV-2 infection. HH-120 is an angiotensin converting enzyme 2 (ACE2) Fc fusion protein. Clinical data. Web11 sep. 2024 · September 14, 2024 updated by: Huahui Health. A Randomized, Double-blind, Placebo-controlled Phase Ib Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Multiple-dose HH-003 Injection in Treatment Naïve Participants With HBeAg-positive Chronic HBV Infection.
Huahui healthcare
Did you know?
Web9 mrt. 2024 · HUAHUI HEALTH (AUS) PTY LTD (ACN: 653385972) was incorporated on 03/09/2024 in Australia. Their business is recorded as Australian Proprietary Company, … Web2 mrt. 2024 · Huahui Health is developing a treatment for Hepatitis B virus. This study is designed to evaluate the safety and tolerability of HH-006, a hepatitis virus neutralizing …
WebHealth management and winning practice articles, value-based healthcare, healthcare events, company and product directory, I-I-I videos and I-I-I blog interviews. Web31 jan. 2024 · Huahui Health Study record dates These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website. Study Major …
WebSee your life in amazing detail with HUAWEI Health App’s health stats. Keep an easy-to-access record of your heart rate, blood oxygen levels, blood pressure, sleep quality, step … Web6 feb. 2024 · Huahui Health Study Details Tabular View No Results Posted Disclaimer How to Read a Study Record Study Description Go to Brief Summary: This is a randomized, double-blind, placebo-controlled Phase 2 study in participants over the age of 18 years with mild COVID-19.
Web13 dec. 2024 · Huahui Health is actively pursuing global clinical development of HH-120. A randomized, double-blinded, placebo-controlled Phase I study is currently ongoing in …
Web6 feb. 2024 · Huahui Health Investigators None specified. Study Documents (Full-Text) None provided. More Information Publications None provided. Responsible Party: Huahui Health ClinicalTrials.gov Identifier: NCT05713318 Other Study ID Numbers: HH120-NS215 First Posted: Feb 6, 2024 Last Update Posted: Feb 6, 2024 Last Verified: Feb 1, 2024 maria pastry shopWebHealth management and winning practice articles, value-based healthcare, healthcare events, company and product directory, I-I-I videos and I-I-I blog interviews. User … maria pawlowna gesellschaft weimarWeb8 jan. 2024 · Latest HUAHUI HEALTH LTD. Patents: Anti-pre-S1 HBV antibodies A METHOD OF TREATING HBV INFECTION BY USING ANTI-PRE-S1 HBV ANTIBODIES ANTI-FGF19 ANTIBODIES POLYMERIC BILE ACID DERIVATIVES INHIBIT HEPATITIS B AND D VIRUS AND NTCP TRANSPORT Skip to:Description · Claims · References … natural golden sea mossWebHuahui XIONG Cited by 130 of Capital Medical University, Beijing (CCMU) Read 12 publications Contact Huahui XIONG maria payer watercolorsWeb1 aug. 2024 · 2024年8月1日，华辉安健宣布任命在创新药物研发，临床开发与注册，商务拓展等领域拥有丰富经验的陈彬博士担任公司首席执行官，全面领导公司业务发展。陈彬 … natural goldendoodleWebHuahui Health May 2024 - Present11 months 中国 北京市 Beijing Shenogen Biomedical Co., Ltd 8 years 10 months VP Medical Sci & Translational Biomarker Jun 2024 - Present5 years 10 months Executive... natural golden hairWebLegal Name Huahui Health Ltd. Company Type For Profit Contact Email [email protected] Phone Number 010-80766688 Huahui Health engages in the R&D of innovative drugs … natural gold eyes